MET and renal cell carcinoma: A study examining six cases of SDH-deficient RCC by next-generation DNA sequencing showed that none of the examined cases harbored genetic mutations that contribute to RCC pathogenesis, including VHL, PIK3CA, AKT, MTOR, MET, and TP53 [70].